A four-year agreement reached between Medicines for Ireland and the Irish government offers suppliers visibility and stability thanks to a combination of clear pricing mechanisms as well as the promise of uptake drivers, the off-patent industry association says.
A four-year agreement struck between Medicines for Ireland and the Irish government will offer “certainty for launch planning” for players in Ireland’s off-patent market thanks to a combination of clear long-term pricing mechanisms and drivers for generic and biosimilar uptake, the industry association believes.
Commenting after the announcement of the agreement – which runs from 1 December 2021 to 30 November 2025 – Medicines...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Also, Latest News From Europe, Canada, Saudi Arabia, Finland, China, And The US
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
